Highly ordered titania nanotube arrays for phosphoproteomics
10478800 ยท 2019-11-19
Assignee
Inventors
- Oomman K. Varghese (Houston, TX, US)
- Aruna Wijeratne (West Lafayette, IN, US)
- Maggie Paulose (Houston, TX, US)
- Ivy Ahiabu (Houston, TX, US)
- Kenneth D. Greis (Fort Thomas, KY, US)
- Dharshana Wijesundara (Houston, TX, US)
- Wei-Kan Chu (Pearland, TX, US)
Cpc classification
C07K1/22
CHEMISTRY; METALLURGY
C01P2004/61
CHEMISTRY; METALLURGY
C25D11/26
CHEMISTRY; METALLURGY
B01J20/3085
PERFORMING OPERATIONS; TRANSPORTING
C01P2004/62
CHEMISTRY; METALLURGY
B01J20/28085
PERFORMING OPERATIONS; TRANSPORTING
B01D15/3828
PERFORMING OPERATIONS; TRANSPORTING
C01P2002/72
CHEMISTRY; METALLURGY
B01J20/06
PERFORMING OPERATIONS; TRANSPORTING
B01J20/28083
PERFORMING OPERATIONS; TRANSPORTING
C01P2004/64
CHEMISTRY; METALLURGY
International classification
B01J20/06
PERFORMING OPERATIONS; TRANSPORTING
B01D15/38
PERFORMING OPERATIONS; TRANSPORTING
B01J20/30
PERFORMING OPERATIONS; TRANSPORTING
C25D11/26
CHEMISTRY; METALLURGY
B01J20/28
PERFORMING OPERATIONS; TRANSPORTING
C07K1/22
CHEMISTRY; METALLURGY
Abstract
Titania nanotube arrays are useful for phosphopeptide enrichment and separation. These highly ordered titania nanotube arrays are a low cost and highly effective alternative to the use of liquid chromatography mass spectrometry (LC-MS) methods using meoporous titania beads or particles. The highly ordered TiO.sub.2 nanotubes are grown on surfaces coated with Ti metal, or preferably on Ti wires, by methods that preferably include anodic oxidation.
Claims
1. A device for isolation of phosphopeptides in a sample, comprising: an ordered TiO.sub.2 nanotube array comprising ordered TiO.sub.2 nanotubes grown on a Ti surface, wherein the nanotubes point outward from the Ti surface, wherein the Ti surface is a Ti wire, and wherein the nanotubes point radially outward from the Ti wire; and a container for phosphopeptide isolation, wherein the ordered TiO.sub.2 nanotube array is located within the container, and wherein the sample is placed in the container to contact the ordered TiO.sub.2 nanotube array.
2. The device of claim 1, wherein the ordered TiO.sub.2 nanotubes have a length of about 100 nm to about 500 m and a pore diameter of about 10 nm to about 400 nm.
3. The device of claim 1, wherein the ordered TiO.sub.2 nanotubes have a length of about 10 to about 20 m, a pore diameter of about 110 nm, and a wall thickness of about 20 nm.
4. The device of claim 1, wherein the Ti wire has a diameter of about 0.01 mm to about 1 mm.
5. The device of claim 1, wherein the Ti wire has a diameter of about 0.25 mm.
6. The device of claim 1, wherein the ordered TiO.sub.2 nanotube array is immobilized on the Ti surface.
7. A method for isolation of phosphopeptides in a sample, comprising: exposing a sample containing phosphopeptides to the device of claim 1, wherein the sample is placed in the container and wherein the sample contacts the ordered TiO.sub.2 nanotube array to produce bound phosphopeptides attached to the ordered TiO.sub.2 nanotube array; and releasing the bound phosphopeptides from the ordered TiO.sub.2 nanotube array to produce isolated phosphopeptides.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
(14) The present disclosure relates to titania nanotube arrays useful for phosphopeptide enrichment and separation. These highly ordered titania nanotube arrays are a low cost and highly effective alternative to the use of liquid chromatography mass spectrometry (LC-MS) methods using meoporous titania beads or particles. These beads or particles are expensive and their irregular pore structure offers very limited opportunities for surface manipulation for any further improvement in performance.
(15) In a preferred embodiment, radially aligned nanotubes were grown by anodic oxidation of titanium wires and their performance was compared to widely used commercially available bulk mesoporous titania beads. Peptides generated from a standard phosphoprotein, -casein, as well as mouse liver complex tissue extracts were used for the comparison. Example titania nanotubes of length about 10 to about 20 m, with a pore diameter of about 110 nm and a wall thickness of about 20 nm, demonstrated their capacity to perform on par with the commercially available beads, with further indications that the nanotubes having optimum dimensions could outperform the commercially available phosphopeptide enrichment materials. However, other titania nanotubes having other lengths, pore diameters, and wall thicknesses may also be used, since the optimum dimensions for maximum separation capacity may be outside the ranges recited above. For example, the lengths of the titania nanotubes may range from about 100 nm to about 500 m, and the pore diameter may range from about 10 nm to about 400 nm.
(16) Thus, the highly porous nature of the commercially available bulk material, which has been effective for phosphopeptide separation, is also achieved in preferred embodiments of the highly ordered TiO.sub.2 nanotubes grown on Ti metal surfaces. In preferred examples, TiO.sub.2 nanotubes coated on Ti-wires were tested for their capacity for phosphopeptide enrichment, and compared to the phosphopeptide separation capacity of the commercially available bulk material beads as a reference. Ti-wires were chosen for nanotube growth because their quantity and effective surface area for phosphopeptide binding could be simply and appropriately tuned based on the wire length. Ideally, controlled/optimized amounts of TiO.sub.2-beads for improved phosphopeptide separation and detection should be used. Thus, instead of controlling the weight of small sample amounts of bulk material beads, the length of Ti-wires bearing titania nanotubes are readily optimized for phosphopeptide separation. Furthermore, the nanotubes coated on Ti wires are immobile, so they do not mix into the solution, hence providing the added benefit of avoiding practical difficulties in separating beads from solvent media. The nanotube array can be immobilized on any suitable solid surface, or it may be utilized without any surface immobilization as a self-stranding membrane. In preferred embodiments, the Ti wire has a diameter from about 0.01 mm to about 1 mm. In additional preferred embodiments, the Ti wire has a diameter of about 0.25 mm.
(17) In additional preferred embodiments, the titania nanotubes are not grown on TI wires. Rather, they are grown inside a container such as a vial. The inside of the container is first coated with titanium, then the titanium is anodized to form the TiO.sub.2 nanotubes. Phosphorylated proteins placed inside the container would then attach to the inside of the container.
(18) Experiments demonstrate that the highly ordered titania nanotube arrays grown on Ti surfaces are highly suitable for isolating phosphopeptides. The arrays perform at an appreciable level as compared to bulk material beads while also possessing other desirable attributes. Importantly, the nanotube dimensions can be further varied in length and diameter, thus one can precisely tune the parameters to further optimize their functionality. In addition, the nanotube-on-wire geometry of preferred embodiments facilitates the use of length of the wire as a way to easily assess the surface area for phosphopeptide separation experiments and thus eliminate the need for weighing precisely very small amounts of enrichment material or the variability associated with using slurry suspensions of material as in the case of beads. Furthermore, the nanotube arrays may be made available at a much lower cost than the present commercially available materials. The TNTs on Ti wire embodiments are shown to offer similar efficacy for phosphopeptide enrichment compared to the current best approach, while at the same time offering an enhanced ease-of-use. It should be noted that titania nanotubes are not the only nanotubes expected to show these advantages. For example, nanotubes made of oxides of alloys of titanium and zinc oxide may also be useful.
EXAMPLE 1
Materials, Preparation, and Characterization of TiO2 Nanotubes on Ti Wire
(19) Guanidine:hydrogen chloride (GHCl), ammonium bicarbonate (NH4HCO3), Phosphatase inhibitor cocktail 2 (cat. no. P5726), dithiothreitol (DTT), iodoacetamide (IAA), formic acid (HCOOH, FA), triflouroacetic acid (TFA), -casein from bovine milk (cat. no. C6780, as-casein minimum 70%), acetonitrile (CHROMASOLV, for HPLC, gradient-grade, >99.9%), water (CHROMASOLV-Plus, for HPLC), -cyano-4-hydroxycinnamic acid (CHCA), and glycolic acid were purchased from Sigma-Aldrich (St. Louis, Mo.). For proteomics sample preparation work-flow, deionized water was obtained from an in-house Milli-Q system (Millipore, Bedford, Mass.). All centrifugation steps were completed in an IEC Micromax RF microfuge at 14,600 RCF (Relative Centrifugal Force). Modified trypsin was obtained from Promega (Madison, Wis.). Oligo R3 reversed-phase material was obtained from Applied Biosystems (Foster City, Calif.). For the packing of Oligo R3 reversed phase material, Bio-select extraction columns (reversed phase C4) were obtained from GRACE-VYDAC (W.R. Grace & Co., Deerfield, Ill.). For TiO.sub.2-chromatography using beads, Titansphere TiO.sub.2-beads were obtained from GL Sciences Inc. For TiO.sub.2-chromatography using wires, titanium wire of diameter 0.25 mm (99.7% pure) purchased from Sigma Aldrich was used. The electrolyte for anodization of the wire consisted of ammonium fluoride (ACS reagent, 98%, Sigma Aldrich) and ethylene glycol (anhydrous, 99.8%, Sigma Aldrich) and deionized water.
(20) Ammonium hydroxide (trace-metal grade, assay: 20-22% as NH.sub.3) was obtained from Fisher Scientific (Hampton, N.J.) for phosphopeptide elution during TiO.sub.2-chromatography. Whole mouse liver samples were dounce homogenized in the presence of both protease and phosphatase inhibitor cocktails (Jarrold et al. 2005). Protein concentrations were also determined using NI (Non-Interfering) Protein Assay-Kit purchased from G-BIOSCIENCES.
(21) The Ti wire (diameter 0.25 mm) was cut into 25 mm length and degreased by sonication in acetone and then in isopropanol. The degreased wires were again cleaned sequentially in water and Micro-90, isopropanol and acetone and dried with nitrogen gas. Anodization was conducted at room temperature in an electrolyte consisting of 0.3 wt % NH.sub.4F, 2 vol % H.sub.2O in Ethylene Glycol. The titanium wire was used as anode and platinum foil as cathode. The anodization was performed for 4 h with 60 V applied between the electrodes. The anodized wires were washed and sonicated in isopropanol to remove debris formed on the surface of the nanotubes during the anodization process. The cleaned samples were annealed at 530 C. in oxygen for 3 h (Varghese et al. 2003).
(22) The morphology of the nanotubes on Ti wire was studied using a field emission scanning electron microscope (FESEM; LEO 15125). The crystal structure was identified using a high resolution transmission electron microscope (HRTEM; JEOL 2010) and glancing angle x-ray diffractometer (GAXRD; Rigaku, Smartlab, Cu K-alpha). An array of three nanotube coated wire was used for GAXRD measurements. The incident angle was 0.5. The x-ray photoelectron spectroscopy (XPS; Physical Electronics, model 5700) was used to determine the composition of the samples.
(23) In order to understand the phosphopeptide separation efficiency of the titania nanotube arrays relative to the most utilized material in the field, TiO.sub.2-chromatography was performed in parallel using, (1) the most popularly used and commercially available Titansphere TiO.sub.2 Bulk Material-beads as a reference material (Beads) and, 2) Ti-wire pieces grown with TiO.sub.2 nanotubes (Wires), on a standard phosphoprotein, -casein and also on mouse liver lysates, to illustrate their phosphopeptide separation capacity, and their applicability in studying complex biological proteomes, respectively. Surfaces of Ti wire pieces were modified with TiO.sub.2-nanotubes (see
(24) Anodization of titanium wires per the conditions given above resulted in the growth of highly ordered nanotubes pointing radially outward from the surface. The SEM image of the cross section of a nanotube-covered Ti wire sample (diameter 0.25 mm) is given in
(25) The anodization of titanium in organic electrolytes such as ethylene glycol generally produces anodization debris in the form of particles or nanowires or bunched/broken tubes on the surface of the sample. To remove the debris from the surface of the nanotubes, the wire samples were subjected to ultrasonic agitation at 35 kHz as used normally for other substrates. However, the nanotube films peeled during sonication due to the stress at the oxide/metal interface. The problem was eliminated by performing the ultrasonication at 130 kHz at a reduced power level for 1 to 2 hours. The resulting films were heat treated in oxygen ambient at 530 C. for stoichiometric TiO.sub.2 formation and crystallization (Varghese et al. 2003).
(26) The low magnification SEM images of a heat treated nanotube coated wire sample are shown in
(27) In order to understand the structure and composition of the heat treated nanotubes on wire substrates, HRTEM, GAXRD and XPS studies were performed.
EXAMPLE 2
Trypsin Digestion, Desalting of Tryptic Peptides, and Separation of Phosphopeptides using TiO2-Chromatography
(28) As reported previously (Wijeratne et al. 2013), 500 g aliquots of protein were precipitated with 8 volumes of cold acetone (20 C.) in 1.5 mL Eppendorf tubes. After centrifugation (14,600 RCF, 5 min), supernatants were discarded and pellets were washed three times using 20 C. acetone (100 L for each wash). Sample tubes were then kept open in a fume-hood for 2 min to ensure any residual acetone vaporization. The pellets were reconstituted in 3 M Guanidine:HCl in 100 mM NH.sub.4HCO.sub.3 (90 L) containing phosphatase inhibitor cocktail (2 L). The solutions were subsequently reduced with DTT (1 mM final concentration, incubated at 37 C., for 45 min) and then alkylated with iodoacetamide (5.5 mM final concentration, incubated at 37 C., for 30 min). The solutions were finally diluted with ddH.sub.2O to 1 mL before trypsin-based digestion. 100 g of modified trypsin was dissolved in 300 L of 0.1 M NH.sub.4HCO.sub.3, and 10 g aliquots were added into each 500 g protein sample (i.e. 1:50 weight ratio). Samples were then incubated overnight at 37 C., and the digestion was quenched by adding 20 L of formic acid (to bring the pH of solutions to less than 5). After centrifugation, the supernatants were recovered for further processing. Similarly, 500 g of bovine -casein was subjected to trypsin digestion for qualitative comparison of phosphopeptide separation using Titansphere TiO.sub.2 Bulk Material-beads (beads) and Ti-wire surface grown with TiO.sub.2 nanotubes (wires).
(29) Oligo R3 reversed-phase material was dispersed in ACN/H.sub.2O/TFA 70/29.9/0.1 (v/v/v) to make a 60 mg/mL slurry as previously described (Wijeratne, et al. 2013; Thingholm, et al. 2008), and divided into 500 L aliquots each containing 30 mg of Oligo R3 beads in 1.5 mL Eppendorf tubes. The beads prepared for peptide desalting by sequential vortex, spin and removal of the supernatant followed by two wash steps using 200 L of 0.1% TFA in MilliQH.sub.2O. Peptide solutions were added onto washed Oligo R3 beads and incubated for 30 min at room-temperature using end-over-end rotation. GRACE-VYDAC BIOSELECT-C4 columns (CAT. NO. 214SPE1000) were adapted onto an extraction manifold (Waters Manifold, Mass., USA), washed sequentially with 1) ACN (500 L), 2) ACN/TFA/H.sub.2O 70/0.1/29.9 (v/v/v, 200 L), 3) 0.1% TFA (500 L) and 4) dd H.sub.2O (500 L), and then packed with peptide-bound Oligo R3 beads by a gentle application of vacuum into the extraction manifold vacuum chamber. Subsequently, the peptide-bound beads were washed with 500 L ddH.sub.2O and eluted by sequentially passing 200 L of ACN/TFA/H.sub.2O 90/0.1/9.9 (v/v/v) for one time and then 200 L of ACN/TFA/H.sub.2O 70/0.1/29.9 (v/v/v) for two times. All elution fractions were collected into 1.5 mL Eppendorf tubes. Prior to TiO.sub.2-chromatography, these elution fractions were subjected to vacuum centrifugation for complete dryness.
(30) Phosphopeptide separation of the peptide mixtures was carried out using an optimized strategy adapted from previous reports ((Wijeratne, et al. 2013; Thingholm, et al. 2008; Li, et al. 2009), and was performed in triplicate using identical protein samples for each TiO.sub.2-chromatographic method. In using the beads for phosphopeptide separation, briefly for each replicate, Titansphere TiO.sub.2 beads were dispersed in ACN/H.sub.2O/TFA 80/15/5 (v/v/v) to make a 100 g/L slurry and then divided into 5 L aliquots each containing 500 g of TiO.sub.2 beads in 0.5 mL Eppendorf tubes. Each vial was subjected to a vortex and spin with supernatants discarded, followed by 2 additional wash steps using 200 L of 0.1% TFA in MilliQH.sub.2O. Dried peptide mixtures (500 g) were reconstituted in 200 L of 1 M glycolic acid in ACN/H.sub.2O/TFA 80/15/5 (v/v/v), and loaded onto the pre-washed Titansphere TiO.sub.2-beads. The peptides were allowed to interact with the TiO.sub.2 for 30 min at room temperature using end-over-end rotation. The TiO.sub.2 beads were then sequentially washed with 400 L ACN/H.sub.2O/TFA 80/15/5 (v/v/v) with a spin and removal of the supernatant followed by an additional 400 L wash with the same solvent. Finally the phosphopeptides captured on the TiO.sub.2-beads were eluted 1 time with 200 L of 5% NH.sub.4OH. In using the wires for phosphopeptide separation, briefly for each replicate, Ti-wire pieces (40.5 cm, i.e. 2.0 cm in length) grown with TiO.sub.2 nanotubes were placed inside 0.5 mL Eppendorf tubes and subjected to similar washing steps. Following reconstitution of dried peptide mixtures (500 g) in 200 L of 1 M glycolic acid in ACN/H.sub.2O/TFA 80/15/5 (v/v/v), peptide mixtures were loaded onto the pre-washed Ti-wire pieces grown with TiO.sub.2 nanotubes. TiO.sub.2 wires with loaded peptides were then sequentially washed with 400 L ACN/H20/TFA 80/15/5 (v/v/v) with a spin and removal of the supernatant followed by an additional 400 L wash with the same solvent. Finally the phosphopeptides captured on the TiO.sub.2-wires were also eluted 1 time with 200 L of 5% NH.sub.4OH. The NH.sub.4OH elution fractions were dried by vacuum centrifugation prior to nanoLC-MS/MS analysis. For the standard phosphopeptide mixture obtained from -casein trypsin digestion, 2.5 L aliquots of the elution fractions were removed from each sample, desalted by ZipTip(C-18) as described by the manufacturer (Millipore) and evaluated by Matrix-assisted Laser Desorption IonizationTime of FlightMass Spectrometry (MALDI-TOF-MS) to qualitatively investigate phosphopeptide separation.
(31) MALDI-MS analysis was performed on a 4800 MALDI-TOF/TOF instrument (AB Sciex, Foster city, Calif.). Mass spectra were obtained in positive ion reflector mode. MALDI-matrix solution was prepared by dissolving -cyano-4-hydroxy-cinnamic acid (CHCA, 5 mg) in 10 mM ammonium phosphate (monobasic) in ACN/FA/H.sub.2O 60/0.1/39.9 (v/v/v, 1 mL). In order to perform MALDI-MS analyses, desalted (using Oligo R3 reversed phase material or ZipTip (C-18 )) and isolated peptides in solution (0.5 L) were mixed with MALDI-matrix solution (1 L), and spots were placed on a calibrated MALDI plate.
(32) For the qualitative evaluation of phosphopeptide separation capacity of highly ordered TiO.sub.2 nanotubes on Ti-Metal wires prepared, phosphopeptide separation experiments were first performed using a standard phosphoprotein, -casein. As illustrated in
EXAMPLE 3
Phosphopeptide Separation Capacity for Phosphoproteomes of Complex Tissue Samples
(33) In real biological protein samples or proteomes, it is known that phosphorylation is sub-stoichiometric or very low in abundance. Thus, separation of phosphopeptides from a purified standard phosphoprotein sample like the test case with -casein may have different dynamics to that of a complex digestion derived from a tissue extract. Hence, the capacity of the highly ordered TiO.sub.2 nanotubes in phosphopeptide separation for studying complex phosphoproteomes derived from tissue extracts was also compared with respect to the widely used Titansphere TiO.sub.2 Bulk Material-beads.
(34) Nano-LC-MS/MS analyses were performed on a TripleTOF 5600 (ABSciex, Toronto, ON, Canada) coupled to an Eksigent (Dublin, Calif.) nanoLC.ultra nanoflow system. Dried phosphopeptide samples were reconstituted in FA/H.sub.2O 0.1/99.9 (v/v,) and loaded onto IntegraFrit Trap Column (outer diameter of 360 m, inner diameter of 100, and 25 m packed bed) from New Objective, Inc. (Woburn, Mass.) at 2 l/min in FA/H20 0.4/99.2 (v/v) for 10 min to desalt and concentrate the samples. For the chromatographic separation of peptides, the trap-column was switched to align with the analytical column, Acclaim PepMap100 (inner diameter of 75 m, length of 15 cm, C18 particle sizes of 3 m and pore sizes of 100 ) from Dionex-Thermo Fisher Scientific (Sunnyvale, Calif.). The peptides were eluted using a varying mobile phase (MP) gradient from 95% phase A (FA/H.sub.2O 0.4/99.6, v/v) to 40% phase B (FA/ACN 0.4/99.6, v/v) for 70 min, from 40% phase B to 85% phase B for 5 min and then keeping the same MP-composition for 5 more minutes at 300 nL/min.
(35) Nano-LC mobile phase was introduced into the mass spectrometer using a NANOSpray III Source (AB Sciex, Toronto, On, Canada). Ion source gas 1 (GS1) was zero grade air while ion source gas 2 (GS2) and curtain gas (CUR) were both nitrogen. The gas settings were kept at 7, 0 and 25 respectively in vendor specified arbitrary units. Interface heater temperature and ion spray voltage was kept at 150 C., and at 2.3 kV. The mass spectrometer method was operated in positive ion mode set to go through 4156 cycles for 90 minutes, where each cycle consisted of one TOF-MS scan (0.25 s accumulation time, in a 400 to 1600 m/z window) followed by twenty information dependent acquisition (IDA) mode MS/MS-scans on the most intense candidate ions selected from initially performed TOF-MS scan during each cycle, having a minimum of 150 counts. Each product ion scan was operated under vender specified high-sensitivity mode with an accumulation time of 0.05 secs and a mass tolerance of 50 mDa. Former MS/MS-subjected candidate ions were excluded for 10 s after its first occurrence, and data were recorded using Analyst-TF (1.5.1) software.
(36) The nano-LC-MS/MS data (*.wiff file) from the enriched phosphopeptides were analyzed for peptide/protein identification using ProteinPilot software (version 4.2, revision 1297) that integrates the Paragon algorithm, searched against a SwissProt database of Mus Musculus protein sequences on a local 12-processor server. A custom sample-type was selected that specifies variable biological modifications as specified defaults in the ProteinPilot software. The vendor defined phosphorylation emphasis on serine/threonine/tyrosine was also used as a special factor. The resulting *.group files were then used to generate a spreadsheet as a peptide summary report. Only those phosphopeptides identified with a minimum of 95% confidence in identity (calculated by probability algorithms of ProteinPilot software), and phosphorylation as a modification were selected as viable phosphopeptide identifications. Unique phosphopeptides were then selected based on sequence, modifications, and mass to charge ratio (m/z-value) using available software tools on Microsoft Excel. Tools made available by Microsoft Excel were used to determine the number of unique phosphopeptides for each replicate and each TiO.sub.2-chromatography method employed.
(37) In order to examine the capability of TiO.sub.2 nanotubes for phosphopeptide separation in proteomes of complex samples, it was hypothesized that the number of high confidence (>95%) unique phosphopeptides identified using LC-MS/MS and database search algorithms is representative of the phosphopeptide separation capacity in a single phosphopeptide isolation. Hence, an experimental workflow, as depicted in
(38) The average number of high confidence phosphopeptides (Paragon plus algorithm assigned confidence >95%) identified and their average number of representative phosphoproteins were presented as bar-graphs,